Rapid pace of COVID-19 vaccinations – Mayo Clinic News Network

Tens of millions of persons in the U.S. are being vaccinated for COVID-19. However, dialogue is ongoing as to whether folks who are immunocompromised, this kind of as clients going through cancer remedy, or people who have autoimmune diseases, should be vaccinated for COVID-19.

“Both of these categories (of men and women) should really be vaccinated,” says Dr. Gregory Poland, an infectious illnesses skilled and head of Mayo Clinic’s Vaccine Analysis Team. “All those are not contraindications. All those are indications to get the vaccine.” He provides that exploration is ongoing, but recent information and facts demonstrates the positive aspects far outweigh the theoretical hazards.

In this Mayo Clinic Q&A podcast, Dr. Poland talks about vaccine hesitancy, and clients who are immunocompromised or have autoimmune disorders. Also, he discusses next ways in the journey to vaccinate youngsters for COVID-19. And he assessments latest steerage from the Centers for Condition Control and Avoidance Command about in-human being gatherings.

Observe: Dr. Poland discusses the immediate pace of COVID-19 vaccinations.


Read through the complete transcript.


For the protection of its patients, personnel and visitors, Mayo Clinic has strict masking policies in location. Anyone revealed without a mask was both recorded prior to COVID-19 or recorded in a nonpatient-treatment area in which social distancing and other basic safety protocols were adopted.

Info in this article was precise at the time of its publishing. Due to the fluid nature of the COVID-19 pandemic, scientific comprehension, together with pointers and suggestions, may possibly have modified considering that the unique publication day

Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp.and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & JohnsonHonoraria: Elsevier.

For extra data and all your COVID-19 protection, go to the Mayo Clinic News Network and mayoclinic.org.

Learn far more about tracking COVID-19 and COVID-19 developments.